共 50 条
Burden of atopic dermatitis in Asia
被引:70
|作者:
Tsai, Tsen-Fang
[1
,2
]
Rajagopalan, Murlidhar
[3
]
Chu, Chia-Yu
[1
,2
]
Encarnacion, Lonabel
[4
]
Gerber, Robert A.
[5
]
Santos-Estrella, Paul
[6
]
Llamado, Lyndon John Q.
[6
]
Tallman, Anna M.
[7
]
机构:
[1] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[3] Apollo Hosp, Chennai, Tamil Nadu, India
[4] St Lukes Med Ctr, Quezon City, Philippines
[5] Pfizer Inc, Groton, CT 06340 USA
[6] Pfizer Inc, Makati, Philippines
[7] Pfizer Inc, New York, NY USA
来源:
关键词:
Asia;
atopic dermatitis;
eczema;
epidemiology;
quality of life;
PARTY DIAGNOSTIC-CRITERIA;
QUALITY-OF-LIFE;
HEALTH-CARE-SYSTEM;
PREVALENCE;
CHILDREN;
ECZEMA;
GUIDELINES;
MANAGEMENT;
IMPACT;
ASTHMA;
D O I:
10.1111/1346-8138.15048
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
Atopic dermatitis is a chronic, inflammatory skin disease characterized by intense pruritus and eczematous lesions. It is considered one of the most common chronic conditions, with an estimated global prevalence of nearly 230 million. As in the rest of the world, prevalence of atopic dermatitis has been increasing in Asian countries over the last few decades. This increased prevalence in Asian countries has been attributed to factors such as rapid urbanization, increasingly Westernized lifestyles, and improved standards of living and education. As a result, it is important to understand the increasing burden of disease in Asian countries and the differences between the countries in terms of epidemiology, diagnostic criteria, management, quality of life and economic burden.
引用
收藏
页码:825 / 834
页数:10
相关论文